Revision in intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 ( LODR ) dated 09th June 2025 for allotment of equity shares under Employees Stock Option Plan 2008 ( ESOP 2008 ) and Management ESOP Plan 2018 ( Management ESOP 2018 ).
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has revised its earlier intimation regarding allotment of equity shares under its employee stock option plans. The company is withdrawing a prior intimation dated 23rd May 2025 for 174 shares, which it says was filed inadvertently. The revised allotment (dated 9th June 2025) covers 14,000 shares under the Management ESOP 2018 at an exercise price of Rs 23.30 per share and 5,000 shares under the ESOP 2008 at Rs 188.90 per share, totaling 19,000 equity shares of Re. 1 face value. The company raised about Rs 12.7 lakh in total from these ESOP exercises. Post-allotment, total issued shares stand at 20,85,04,899. There is no lock-in on these shares, and they are identical to existing equity shares.
This is a routine correction of an earlier ESOP allotment disclosure with minimal impact on shareholders. The 19,000 new shares represent a very small dilution (well under 0.01%) of the total share base, so there is no meaningful effect on stock price or shareholder value.